The Medical Advertising Hall of Fame (MAHF) revealed its 2026 inductees Tuesday morning. The organization will induct Lee Maniscalco, the former Chairman and CEO of Haymarket Media, and Ed Wise, the ...

Born and raised in Kosovo, Shehu discusses his path to America and AstraZeneca, and shares advice on what helped him along the way.

US lawsuit accuses company of "disseminating materially false and misleading statements and/or concealing material adverse facts" about the "true state of WPP’s media arm" ahead of profit warning in ...

Companies running private Medicare and Medicaid insurance plans inaccurately list many mental health professionals as being available to treat the plans’ members, a new federal watchdog report says.

AbbVie said its Rinvoq showed superiority over the company’s previous bestselling drug Humira in a head-to-head trial. Results showed that 43% of patients compared to 22% of patients on Humira ...

Looking past the richness of content seemingly unrelated to what we do in pharma is a huge miss. Spaces like Blackweek can provide us with that understanding and inspiration.

Nationwide, states are racing to win their share of a new $50 billion rural health fund. But helping rural hospitals, as originally envisioned, is quickly becoming a quaint idea.

The Idaho Medical Freedom Act makes it illegal to require anyone to take a vaccine or receive “medical intervention.” Leslie Manookian, the activist behind the law, hopes to make it a “societal norm” ...

The red panda character with neuroblastoma helps young patients cope in this effort from Neon and United Therapeutics.

While the AI convo often revolves around generative AI, it’s the AI systems capable of powering the future of marketing that generate the most excitement. AI will replace sales reps as the center of ...

Acadia Pharmaceuticals CEO Catherine Owen Adams breaks down the company’s recent rebrand, its expansion into rare disease marketing and how it’s using AI.

President Trump wants to lower GLP-1 prices; Novo Nordisk hires new corporate affairs lead; FDA announces priority drug review candidates.